相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study
Andreas Glenthoj et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
An online tool for predicting the prognosis of cancer patients with SARS-CoV-2 infection: a multi-center study
Congkuan Song et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Covid-19 intensive care admissions and mortality among swedish patients with cancer
Gunnar Larfors et al.
ACTA ONCOLOGICA (2021)
Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan
Shohei Nakamura et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19
Glenn J. Hanna et al.
ORAL ONCOLOGY (2021)
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
Aljosja Rogiers et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study
Maria Gonzalez-Cao et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
The impact of lockdown during the COVID-19 pandemic on newly acute myeloid leukemia patients: Single-centre comparative study between 2019 and 2020 cohorts in Madrid
Fernando Martin-Moro et al.
LEUKEMIA RESEARCH (2021)
Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom
Catherine Garnett et al.
LEUKEMIA & LYMPHOMA (2021)
Multivariate mortality analyses in COVID-19: Comparing patients with cancer and patients without cancer in Louisiana
Michael J. Lunski et al.
CANCER (2021)
Clinical characteristics and risk factors for in-hospital mortality of lung cancer patients with COVID-19: A multicenter, retrospective, cohort study
Lei Nie et al.
THORACIC CANCER (2021)
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
Anup S. Pathania et al.
THERANOSTICS (2021)
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Wenhua Liang et al.
LANCET ONCOLOGY (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
L. Zhang et al.
ANNALS OF ONCOLOGY (2020)
COVID-19 infection: the perspectives on immune responses
Yufang Shi et al.
CELL DEATH AND DIFFERENTIATION (2020)
Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid
J. Rogado et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2
Cassandra L. Atzrodt et al.
FEBS JOURNAL (2020)
Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy)
Elisa Maria Stroppa et al.
FUTURE ONCOLOGY (2020)
Clinical characteristics and outcomes of cancer patients with COVID-19
Fan Yang et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak
Mengyuan Dai et al.
CANCER DISCOVERY (2020)
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
Vikas Mehta et al.
CANCER DISCOVERY (2020)
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
Lennard Y. W. Lee et al.
LANCET (2020)
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer et al.
LANCET (2020)
COVID-19 and Italy: what next?
Andrea Remuzzi et al.
LANCET (2020)
Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study
Jianbo Tian et al.
LANCET ONCOLOGY (2020)
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
Kunyu Yang et al.
LANCET ONCOLOGY (2020)
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
Jing Yu et al.
JAMA ONCOLOGY (2020)
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
Souad Assaad et al.
EUROPEAN JOURNAL OF CANCER (2020)
SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death
Ramon Yarza et al.
EUROPEAN JOURNAL OF CANCER (2020)
Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies
Jose Maria Sanchez-Pina et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy
Stephen Booth et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
Anthony R. Mato et al.
BLOOD (2020)
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy
Thomas A. Fox et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
COVID-19 outcomes of patients with gynecologic cancer in New York City
Olivia D. Lara et al.
CANCER (2020)
Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan, China
Hongyan Zhang et al.
CANCER (2020)
Disparities in Cancer Outcomes Due to COVID-19-A Tale of 2 Cities
Onyinye D. Balogun et al.
JAMA ONCOLOGY (2020)
Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London
Beth Russell et al.
FRONTIERS IN ONCOLOGY (2020)
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
Bo Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
Marina Chiara Garassino et al.
LANCET ONCOLOGY (2020)
Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission
Qiubai Li et al.
LEUKEMIA (2020)
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
Lydia Scarfo et al.
LEUKEMIA (2020)
Clinical characteristics and risk factors for mortality in hematologic patients affected By COVID-19
Chiara Cattaneo et al.
CANCER (2020)
Determinants of COVID-19 disease severity in patients with cancer
Elizabeth V. Robilotti et al.
NATURE MEDICINE (2020)
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)
Astrid Lievre et al.
EUROPEAN JOURNAL OF CANCER (2020)
A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19
Emre Yekeduz et al.
EUROPEAN JOURNAL OF CANCER (2020)
Inflammatory markers in gynecologic oncology patients hospitalized with COVID-19 infection
Maria Smith et al.
GYNECOLOGIC ONCOLOGY (2020)
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
David J. Pinato et al.
CANCER DISCOVERY (2020)
Chemotherapy and COVID-19 Outcomes in Patients With Cancer
Justin Jee et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies
Yaogong Wu et al.
LEUKEMIA & LYMPHOMA (2020)
Cancer inpatients with COVID-19: A report from the Brazilian National Cancer Institute
Andreia C. de Melo et al.
PLOS ONE (2020)
Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality
Joaquin Martinez-Lopez et al.
BLOOD CANCER JOURNAL (2020)
A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort study
Chao Liu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort
Laurence Albiges et al.
NATURE CANCER (2020)
Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study
Abdul Rahman Jazieh et al.
JCO GLOBAL ONCOLOGY (2020)
Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data
Vassilis G. Giannakoulis et al.
JCO GLOBAL ONCOLOGY (2020)
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
Perrine Vuagnat et al.
BREAST CANCER RESEARCH (2020)
Chemotherapy-induced genotoxic damage to bone marrow cells: long-term implications
Jennifer E. May et al.
MUTAGENESIS (2018)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
The systemic immune response to trauma: an overview of pathophysiology and treatment
Janet M. Lord et al.
LANCET (2014)
Significant Impairment in Immune Recovery After Cancer Treatment
Duck-Hee Kang et al.
NURSING RESEARCH (2009)
Lung infections after cancer chemotherapy
Sandro Vento et al.
LANCET ONCOLOGY (2008)